Van Hulzen Asset Management’s Globus Medical GMED Stock Holding History

Van Hulzen Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.6M	Buy	32,869 +2,000	+6%	+$170K	0.18%	96
2026 Q1	$2.66M	Buy	30,869 +100	+0.3%	+$8.98K	0.2%	88
2025 Q4	$2.69M	Hold	30,769	–	–	0.2%	87
2025 Q3	$1.76M	Hold	30,769	–	–	0.13%	116
2025 Q2	$1.82M	Sell	30,769 -100	-0.3%	-$6.46K	0.15%	107
2025 Q1	$2.26M	Hold	30,869	–	–	0.21%	94
2024 Q4	$2.55M	Hold	30,869	–	–	0.19%	94
2024 Q3	$2.21M	Sell	30,869 -150	-0.5%	-$10.6K	0.16%	106
2024 Q2	$2.12M	Sell	31,019 -19,850	-39%	-$1.19M	0.14%	105
2024 Q1	$2.73M	Hold	50,869	–	–	0.18%	93
2023 Q4	$2.71M	Hold	50,869	–	–	0.19%	87
2023 Q3	$2.53M	Hold	50,869	–	–	0.19%	85
2023 Q2	$3.03M	Hold	50,869	–	–	0.26%	74
2023 Q1	$2.88M	Buy	+50,869	New	+$3.26M	0.27%	73

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Van Hulzen Asset Management's GMED Position: Q2 2026 in Review

Van Hulzen Asset Management increased its Globus Medical (GMED) stake by 6.5% in Q2 2026, buying an estimated $170K and bringing the position to 32,869 shares worth $2.6M. The position accounts for 0.18% of the portfolio, ranked #96.

Van Hulzen Asset Management first reported a position in GMED in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.03M in Q2 2023. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Van Hulzen Asset Management held 32,869 shares of Globus Medical worth $2.6M as of Q2 2026.
Van Hulzen Asset Management bought 2,000 Globus Medical shares in Q2 2026, an estimated $170K.
Globus Medical made up 0.18% of Van Hulzen Asset Management's portfolio in Q2 2026, its #96 holding.
Van Hulzen Asset Management first reported a position in Globus Medical in Q1 2023 and has held it in 14 quarters since.
Van Hulzen Asset Management's Globus Medical position peaked at $3.03M in Q2 2023.
596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Van Hulzen Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.